NIHON CHOUZAI Co.,Ltd. Provides Consolidated Earnings Forecast for the First Half and Full Year of Fiscal Year Ending March 31, 2023
July 29, 2022 at 02:00 am EDT
Share
NIHON CHOUZAI Co.,Ltd. provided consolidated earnings forecast for the first half and full year of fiscal year ending March 31, 2023. For the first half, the company expects net sales to be JPY 156,000 million, Operating profit to be JPY 2,600 million, Profit attributable to owners of parent to be JPY 1,000 million and net income per share to be JPY 33.35.
For the full year, the company expects net sales to be JPY 321,400 million, Operating profit to be JPY 8,500 million, Profit attributable to owners of parent to be JPY 4,400 million and net income per share to be JPY 146.73.
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.